Balchem Corporation (BCPC)
| Market Cap | 5.49B +11.1% |
| Revenue (ttm) | 1.11B +9.4% |
| Net Income | 170.85M +14.5% |
| EPS | 5.30 +16.0% |
| Shares Out | 31.78M |
| PE Ratio | 32.58 |
| Forward PE | 28.10 |
| Dividend | $0.40 (0.23%) |
| Ex-Dividend Date | Dec 31, 2026 |
| Volume | 86,098 |
| Open | 174.12 |
| Previous Close | 173.54 |
| Day's Range | 170.78 - 174.12 |
| 52-Week Range | 147.18 - 186.15 |
| Beta | 0.85 |
| Analysts | Buy |
| Price Target | 213.50 (+23.63%) |
| Earnings Date | Oct 23, 2026 |
About BCPC
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended ... [Read more]
Financial Performance
In 2025, Balchem's revenue was $1.04 billion, an increase of 8.75% compared to the previous year's $953.68 million. Earnings were $154.85 million, an increase of 20.53%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for BCPC stock is "Buy." The 12-month stock price target is $213.5, which is an increase of 23.63% from the latest price.
News
Balchem Corporation to Participate in Baird's Global Industrial Conference on November 11, 2026
MONTVALE, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in Ba...
Balchem price target lowered to $210 from $215 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Balchem (BCPC) to $210 from $215 and keeps a Buy rating on the shares. The company reported a modest sales miss and…
Balchem Earnings Call Transcript: Q3 2026
Q3 delivered record revenue, net income and adjusted EBITDA, with growth across all segments and margin expansion. Management expects healthy YoY growth in Q4 despite normal sequential seasonality; inflation and geopolitical supply risks remain relevant.
Balchem Earnings release: Q3 2026
Balchem released its Q3 2026 earnings on October 23, 2026, summarizing the period's financial results.
Balchem Slides: Q3 2026
Balchem has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 23, 2026.
Balchem Quarterly report: Q3 2026
Balchem has published its Q3 2026 quarterly earnings report on October 23, 2026.
Balchem reports Q3 adjusted EPS $1.57, consensus $1.53
Reports Q3 revenue $290.66M, consensus $289.25M. Ted Harris, chairman, president and CEO of Balchem (BCPC), said, “Balchem delivered another excellent quarter, with healthy growth across all three of ...
Balchem Corporation Reports Third Quarter 2026 Financial Results
MONTVALE, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal third quarter ended September 30, 2026.
Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026
MONTVALE, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 23, 2026, at 11:00 AM Eastern Time (ET) to r...
Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in t...
Balchem price target raised to $215 from $190 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Balchem (BCPC) to $215 from $190 and keeps a Buy rating on the shares post the Q2 report. The company reported a…
Balchem Earnings Call Transcript: Q2 2026
Record quarterly results with 11.2% revenue growth, strong margin expansion, and robust performance across all segments. Strategic refinancing and share repurchases enhanced financial flexibility, while ongoing innovation and marketing investments support continued growth.
Balchem Slides: Q2 2026
Balchem has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
Balchem Earnings release: Q2 2026
Balchem released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
Balchem Quarterly report: Q2 2026
Balchem has published its Q2 2026 quarterly earnings report on July 31, 2026.
Balchem reports Q2 adjusted EPS $1.49, consensus $1.42
Reports Q2 revenue $284M, consensus $268.5M. Ted Harris, Chairman, President and CEO of Balchem (BCPC), said, “The second quarter was another very strong quarter for Balchem with healthy growth in…
Balchem Corporation Reports Second Quarter 2026 Financial Results
MONTVALE, N.J., July 31, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal second quarter ended June 30, 2026.
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026
MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 31, 2026, at 11:00 AM Eastern Time (ET) to revi...
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
MONTVALE, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in th...
Balchem Transcript: AGM 2026
The meeting featured real-time virtual voting, board and auditor elections, and approval of executive compensation. All management proposals passed, and final results will be filed with the SEC.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the...
Balchem Earnings Call Transcript: Q1 2026
Record Q1 results with 8.1% revenue growth, strong gains across all segments, and robust cash flow. Continued momentum in branded ingredients, international expansion, and sustainability, with modest margin compression expected due to inflation and geopolitical risks.
Balchem Earnings release: Q1 2026
Balchem released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Balchem Quarterly report: Q1 2026
Balchem has published its Q1 2026 quarterly earnings report on April 30, 2026.
Balchem Slides: Q1 2026
Balchem has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.